The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2025

Filed:

Oct. 02, 2020
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Michael Molhoj, Munich, DE;

Christian Gassner, Penzberg, DE;

Joerg Moelleken, Munich, DE;

Manuel Endesfelder, Wessling, DE;

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 31/00 (2005.12); C07K 16/00 (2005.12); C07K 16/12 (2005.12); C07K 16/22 (2005.12); C12Q 1/37 (2005.12); G01N 21/552 (2013.12); G01N 33/53 (2005.12); G01N 33/537 (2005.12); G01N 33/557 (2005.12); G01N 33/566 (2005.12); G01N 33/569 (2005.12); G01N 33/68 (2005.12);
U.S. Cl.
CPC ...
G01N 33/557 (2012.12); C07K 16/00 (2012.12); C07K 16/1203 (2012.12); C07K 16/22 (2012.12); C12Q 1/37 (2012.12); G01N 21/553 (2012.12); G01N 33/5375 (2012.12); G01N 33/566 (2012.12); G01N 33/56911 (2012.12); G01N 33/56955 (2012.12); G01N 33/6857 (2012.12); C07K 2317/31 (2012.12); C07K 2317/35 (2012.12); C07K 2317/52 (2012.12); C07K 2317/55 (2012.12); C07K 2317/92 (2012.12); G01N 2333/96466 (2012.12);
Abstract

Herein is reported a method for determining the binding affinity of the binding sites of a bivalent full length antibody of the human IgG1 subclass to a homo-multimeric antigen comprising the steps of i) incubating a mixture comprising the antibody and a polypeptide that is derived from lysine-gingipain ofat a pH of from pH 7.5 to pH 8.5, in the presence of a reducing agent, at a temperature of from 30° C. to 42° C., for time of from 10 min. to 240 min. to cleave the antibody into Fabs and Fc-region, and ii) determining the binding affinity of the Fabs of the antibody for its antigen using a surface plasmon resonance method by directly applying the incubated reaction mixture obtained in the previous step in the surface plasmon resonance method and therewith determining the binding affinity of the binding sites of the bivalent full length antibody of the human IgG1 subclass.


Find Patent Forward Citations

Loading…